{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T09:07:51Z","timestamp":1770541671956,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11096-025-01904-4","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:50:41Z","timestamp":1743792641000},"page":"884-890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Drug-related problems experienced by rheumatoid arthritis patients during the first three months of methotrexate use: a longitudinal observational study"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5403-3419","authenticated-orcid":false,"given":"M. A. M.","family":"Oude Lansink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A. S.","family":"Pongers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6018-4409","authenticated-orcid":false,"given":"C. L.","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. F.","family":"Ten Cate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8560-9514","authenticated-orcid":false,"given":"B. J. F.","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2120-354X","authenticated-orcid":false,"given":"V. J. B.","family":"Huiskes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"1904_CR1","first-page":"2451","volume":"63","author":"A Gaffo","year":"2006","unstructured":"Gaffo A, Saag KG, Curtis JR. Treatment of rheumatoid arthritis AJHP. 2006;63:2451\u201365.","journal-title":"Treatment of rheumatoid arthritis AJHP"},{"key":"1904_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82:3\u201318.","journal-title":"Ann Rheum Dis"},{"key":"1904_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s41927-023-00326-x","volume":"7","author":"LL Haegens","year":"2023","unstructured":"Haegens LL, Huiskes VJB, Smale EM, et al. Drug-related problems reported by patients with rheumatic diseases: an observational study. BMC Rheumatol. 2023;7:7.","journal-title":"BMC Rheumatol"},{"key":"1904_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2147\/TCRM.S194921","volume":"15","author":"SN Ma","year":"2019","unstructured":"Ma SN, Zaman Huri H, Yahya F. Drug-related problems in patients with rheumatoid arthritis. Ther Clin Risk Manag. 2019;15:505\u201324.","journal-title":"Ther Clin Risk Manag"},{"key":"1904_CR5","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3899\/jrheum.151212","volume":"43","author":"JR Curtis","year":"2016","unstructured":"Curtis JR, Bykerk VP, Aassi M, et al. Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review. J Rheumatol. 2016;43:1997\u20132009.","journal-title":"J Rheumatol"},{"key":"1904_CR6","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.3899\/jrheum.081204","volume":"36","author":"BJF van den Bemt","year":"2009","unstructured":"van den Bemt BJF, van den Hoogen FHJ, Benraad B, et al. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol. 2009;36:2164\u201370.","journal-title":"J Rheumatol"},{"key":"1904_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s41927-022-00305-8","volume":"6","author":"N Yajima","year":"2022","unstructured":"Yajima N, Kawaguchi T, Takahashi R, et al. Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study. BMC Rheumatol. 2022;6:75.","journal-title":"BMC Rheumatol"},{"key":"1904_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphar.2016.00269","volume":"7","author":"MJ Kooij","year":"2016","unstructured":"Kooij MJ, Heerdink ER, van Dijk L, et al. Effects of telephone counseling intervention by pharmacists (TelCIP) on medication adherence; results of a cluster randomized trial. Front Pharmacol. 2016;7:269.","journal-title":"Front Pharmacol"},{"key":"1904_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/bmjqs-2015-004400","volume":"25","author":"RA Elliott","year":"2016","unstructured":"Elliott RA, Boyd MJ, Salema N-E, et al. Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the new medicine service. BMJ Qual Saf. 2016;25:747\u201358.","journal-title":"BMJ Qual Saf"},{"key":"1904_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/qshc.2003.005926","volume":"13","author":"N Barber","year":"2004","unstructured":"Barber N. Patients\u2019 problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13:172\u20135.","journal-title":"Qual Saf Health Care"},{"key":"1904_CR11","unstructured":"NHS England. NHS New Medicine Service. https:\/\/www.england.nhs.uk\/primary-care\/pharmacy\/pharmacy-services\/nhs-new-medicine-service\/. Accessed 14 Jun 2024."},{"key":"1904_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1524-4733.2003.00202.x","volume":"6","author":"ME Ernst","year":"2003","unstructured":"Ernst ME, Iyer SS, Doucette WR. Drug-related problems and quality of life in arthritis and low back pain sufferers. Value Health. 2003;6:51\u20138.","journal-title":"Value Health"},{"key":"1904_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2022.100969","volume":"13","author":"SK Sah","year":"2022","unstructured":"Sah SK, Ramaswamy S, Ramesh M. Frequency and risk factors for the development of drug related problems among rheumatoid arthritis patients. Clin Epidemiol Glob Health. 2022;13: 100969.","journal-title":"Clin Epidemiol Glob Health"},{"key":"1904_CR14","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1345\/aph.1D531","volume":"38","author":"KK Viktil","year":"2004","unstructured":"Viktil KK, Blix HS, Reikvam A, et al. Comparison of drug-related problems in different patient groups. Ann Pharmacother. 2004;38:942\u20138.","journal-title":"Ann Pharmacother"},{"key":"1904_CR15","unstructured":"New Medicine Service. Intervention interview schedule. Community Pharmacy England. 2011 https:\/\/cpe.org.uk\/wp-content\/uploads\/2021\/08\/NMS-interview-schedule-Aug-2021.pdf. Accessed 22 Mar 2024."}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-01904-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-01904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:36:31Z","timestamp":1748586991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-01904-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-01904-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}]}}